Literature DB >> 14634687

Obesity is associated with impaired coronary collateral vessel development.

M B Yilmaz1, S F Biyikoglu, Y Akin, U Guray, H L Kisacik, S Korkmaz.   

Abstract

BACKGROUND: Chronic myocardial ischaemia due to coronary artery stenosis or occlusion has been shown to increase the growth of coronary collateral circulation. Collateralization leads to increased oxygen delivery to the area at risk and hence may reduce ischaemia, prevent infarction and preserve contractile function. However, there is considerable variation among patient subsets in terms of the presence or degree of collateralization. We aimed to evaluate the relationship between obesity and coronary collateral development in patients with ischaemic heart disease. METHODS AND
RESULTS: In all, 215 patients (mean age, 57.8+/-8.9 y) with body mass index (BMI)> or =30 kg/m(2) were enrolled into our study. A total of 90 age- and sex-matched patients (mean age, 58.7+/-10 y) with BMI<25 kg/m(2) and significant coronary artery disease were selected as a control group. The mean age and distribution of risk factors for coronary heart disease were not significantly different between two groups other than poorer HDL cholesterol and triglyceride profile in obese patients. The mean BMI was significantly higher in the patient group (33.3+/-2.4 vs 22.8+/-1.7, P<0.001). The mean number of diseased vessels and maximum lesion severity were not significantly different between the two groups. The mean Rentrop collateral score of the patient group was significantly worse than the control group (1.08+/-0.68 vs 2.10+/-0.72, P<0.001).
CONCLUSIONS: Our findings suggest that collateral vessel development is poorer in obese patients (defined as BMI> or =30 kg/m(2)) with ischemic heart disease compared to normal range BMI, and the risk of having poor collateral vessel development is significantly increased. However, this might be reflecting the cluster of risk factors, associated with metabolic syndrome, in which insulin resistance plays a major role.

Entities:  

Mesh:

Year:  2003        PMID: 14634687     DOI: 10.1038/sj.ijo.0802474

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  21 in total

Review 1.  Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis.

Authors:  June Yun; Petra Rocic; Yuh Fen Pung; Souad Belmadani; Ana Catarina Ribeiro Carrao; Vahagn Ohanyan; William M Chilian
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

2.  MMPs 2 and 9 are essential for coronary collateral growth and are prominently regulated by p38 MAPK.

Authors:  Tracy Dodd; Rashmi Jadhav; Luke Wiggins; James Stewart; Erika Smith; James C Russell; Petra Rocic
Journal:  J Mol Cell Cardiol       Date:  2011-08-22       Impact factor: 5.000

3.  Impaired compensation to femoral artery ligation in diet-induced obese mice is primarily mediated via suppression of collateral growth by Nox2 and p47phox.

Authors:  Matthew R DiStasi; Julie A Mund; H Glenn Bohlen; Steven J Miller; David A Ingram; Michael C Dalsing; Joseph L Unthank
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-21       Impact factor: 4.733

Review 4.  Adiponectin actions in the cardiovascular system.

Authors:  Teresa A Hopkins; Noriyuki Ouchi; Rei Shibata; Kenneth Walsh
Journal:  Cardiovasc Res       Date:  2006-10-20       Impact factor: 10.787

5.  Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling.

Authors:  G Doronzo; I Russo; L Mattiello; C Riganti; G Anfossi; M Trovati
Journal:  Diabetologia       Date:  2006-02-28       Impact factor: 10.122

Review 6.  Cardioprotection by adiponectin.

Authors:  Noriyuki Ouchi; Rei Shibata; Kenneth Walsh
Journal:  Trends Cardiovasc Med       Date:  2006-07       Impact factor: 6.677

7.  Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesity.

Authors:  Doan T M Ngo; Melissa G Farb; Ryosuke Kikuchi; Shakun Karki; Stephanie Tiwari; Sherman J Bigornia; David O Bates; Michael P LaValley; Naomi M Hamburg; Joseph A Vita; Donald T Hess; Kenneth Walsh; Noyan Gokce
Journal:  Circulation       Date:  2014-08-12       Impact factor: 29.690

8.  Caloric restriction stimulates revascularization in response to ischemia via adiponectin-mediated activation of endothelial nitric-oxide synthase.

Authors:  Megumi Kondo; Rei Shibata; Rie Miura; Masayuki Shimano; Kazuhisa Kondo; Ping Li; Taiki Ohashi; Shinji Kihara; Norikazu Maeda; Kenneth Walsh; Noriyuki Ouchi; Toyoaki Murohara
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

9.  Impaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatin.

Authors:  Tracy Dodd; Luke Wiggins; Rebecca Hutcheson; Erika Smith; Alla Musiyenko; Brenda Hysell; James C Russell; Petra Rocic
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-18       Impact factor: 8.311

10.  NAD(P)H oxidase-derived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivo.

Authors:  Xiaosun Zhou; H Glenn Bohlen; Steven J Miller; Joseph L Unthank
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-03       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.